Additively Versus Subtractively Manufactured Implant Supported Fixed Dental Prostheses

NCT ID: NCT07090863

Last Updated: 2025-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-30

Study Completion Date

2029-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research is being done to evaluate the clinical, technical, biological, and aesthetic results of two different fabrication methods (additive and subtractive) for creating implant-supported fixed dental prostheses (iFDPs). Patients will receive an iFDP, meaning an implant-supported crown, according to regular treatment protocols. The fabrication method used to create the implant-supported crown will be decided in a randomised way. Clinical and radiological examinations will be performed prior to and when receiving the implant-supported crown and during a follow-up period of 3 years. Furthermore, technician- and patient-reported outcomes will be evaluated used questionnaires.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is designed as a randomised controlled clinical trial with a multi-centre design. Patients in need of a definitive posterior implant-supported crown will be enrolled in this study following predefined eligibility criteria at two different study centres (Harvard School of Dental Medicine, Harvard University and Center of Dental Medicine, University of Zurich). Patients will receive a single implant-supported crown fabricated according to group allocation (additively or subtractively manufactured). After crown delivery, patients will be followed-up for an observation period of 3 years. The primary outcome is the clinical performance of the implant crowns. Clinical, technical, biological, and aesthetic results as well as the technician- and patient-reported outcomes will be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Prosthesis, Implant-Supported

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomised controlled clinical trial
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Additive manufacturing

additively manufactured implant-supported prostheses

Group Type EXPERIMENTAL

AM manufacturing method

Intervention Type DEVICE

additively manufactured implant-supported prostheses

Subtractive manufacturing

subtractively manufactured implant-supported prostheses

Group Type ACTIVE_COMPARATOR

SM manufacturing method

Intervention Type DEVICE

subtractively manufactured implant-supported prostheses

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AM manufacturing method

additively manufactured implant-supported prostheses

Intervention Type DEVICE

SM manufacturing method

subtractively manufactured implant-supported prostheses

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed Informed Consent Form in English language
* ≥ 20 years of age
* In need of at least one definitive screw retained premolar or molar iFDP on an existing dental implant (Straumann AG)
* Presence of at least one adjacent tooth at the implant site
* Adequate oral hygiene
* Capability to comply with the study procedures

Exclusion Criteria

* Pregnant or lactating women
* Known or suspected non-compliance, drug or alcohol abuse
* Severe periodontal and peri-implant disease
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Zurich

OTHER

Sponsor Role collaborator

Harvard Medical School (HMS and HSDM)

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

German O. Gallucci

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

German O Gallucci, Professor

Role: PRINCIPAL_INVESTIGATOR

Harvard School of Dental Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Harvard School of Dental Medicine

Boston, Massachusetts, United States

Site Status

Center of Dental Medicine, University of Zurich

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kevser Pala, Dr.med.dent

Role: CONTACT

+41764084037

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

German O Gallucci, Professor

Role: primary

617-432-5764

Kevser Pala, Dr.med.dent

Role: primary

+41764084037

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

3DP-Implant-Crown

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.